AstraZeneca May Have Included 'Outdated' Data in U.S. Vaccine Trials
AstraZeneca may have included out-of-date drug data in information provided during US trials for its Covid-19 vaccine, a regulator said late Monday, citing concerns from a monitoring board.
The board "expressed concern that AstraZeneca may have included outdated information from that trial, which may have provided an incomplete view of the efficacy data," a statement from the National Institute of Allergy and Infectious Diseases said.
Comments
0
